Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

Göran M Ahlgren,Per Flodgren,Teuvo L J Tammela,Pirkko Kellokumpu-Lehtinen,Michael Borre,Anders Angelsen,Jon Reidar Iversen,Asgerdur Sverrisdottir,Eirikur Jonsson,Lisa Sengelov

European Urology（2018）

引用 55|浏览20

暂无评分

摘要

In this randomised trial, docetaxel without hormonal therapy or continuous corticosteroids was given after radical prostatectomy for high-risk prostate cancer. We found no benefit from docetaxel alone given after radical prostatectomy.

查看译文

关键词

Prostate cancer,Adjuvant,Docetaxel,Randomised trial,Radical prostatectomy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要